Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Depreciation Expense (2016 - 2019)

Historic Depreciation Expense for Xtant Medical Holdings (XTNT) over the last 10 years, with Q3 2019 value amounting to $800000.0.

  • Xtant Medical Holdings' Depreciation Expense changed 0.0% to $800000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $3.1 million, marking a year-over-year increase of 3478.26%. This contributed to the annual value of $3.2 million for FY2018, which is 1578.95% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Depreciation Expense of $800000.0 as of Q3 2019, which was down 0.0% from $700000.0 recorded in Q2 2019.
  • In the past 5 years, Xtant Medical Holdings' Depreciation Expense registered a high of $2.0 million during Q3 2017, and its lowest value of -$100000.0 during Q4 2017.
  • Moreover, its 5-year median value for Depreciation Expense was $747850.0 (2016), whereas its average is $653061.0.
  • In the last 5 years, Xtant Medical Holdings' Depreciation Expense tumbled by 13998.75% in 2017 and then soared by 90000.0% in 2018.
  • Over the past 5 years, Xtant Medical Holdings' Depreciation Expense (Quarter) stood at $112750.0 in 2015, then skyrocketed by 121.8% to $250078.0 in 2016, then plummeted by 139.99% to -$100000.0 in 2017, then skyrocketed by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • Its Depreciation Expense was $800000.0 in Q3 2019, compared to $700000.0 in Q2 2019 and $800000.0 in Q1 2019.